Hey, Takeda shareholders: Shire's Q1 may ease some buyout worries, analysts say
admin 26th April 2018 Uncategorised 0On Thursday, Takeda investors got a closer look at the company they may snag a piece of if the Japanese drugmaker’s $64 billion bid for Shire goes through. And analysts see at least a couple of reasons they should be pleased.
More: Hey, Takeda shareholders: Shire's Q1 may ease some buyout worries, analysts say
Source: fierce